Barclays’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.9M Hold
47,500
– – ﹤0.01% 1346
2026
Q2
$22.9M Buy
+47,500
New +$12.6M ﹤0.01% 1059
2025
Q4
– Sell
-85,000
Closed -$16.6M – 5773
2025
Q3
$16.6M Buy
+85,000
New +$14M ﹤0.01% 1337
2024
Q4
– Sell
-3,600
Closed -$189K – 5526
2024
Q3
$189K Buy
+3,600
New +$169K ﹤0.01% 4334

Other funds holding ALAB

Barclays's ALAB Position: Q3 2026 in Review

Barclays increased its Astera Labs (ALAB) stake by 19% in Q3 2026, buying an estimated $70.2M and bringing the position to 1,349,025 shares worth $480M. The position accounts for 0.1% of the portfolio, ranked #127.

Barclays first reported a position in ALAB in Q1 2024 and has held it in 11 quarters since. The position peaked at $546M in Q2 2026. 493 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Barclays held 1,349,025 shares of Astera Labs worth $480M as of Q3 2026.
  • Barclays bought 218,081 Astera Labs shares in Q3 2026, an estimated $70.2M.
  • Astera Labs made up 0.1% of Barclays's portfolio in Q3 2026, its #127 holding.
  • Barclays first reported a position in Astera Labs in Q1 2024 and has held it in 11 quarters since.
  • Barclays's Astera Labs position peaked at $546M in Q2 2026.
  • 493 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.